The small heat shock protein Hsp31 cooperates with Hsp104 to modulate Sup35 prion aggregation.
The yeast homolog of DJ-1, Hsp31, is a multifunctional protein that is involved in several cellular pathways including detoxification of the toxic metabolite methylglyoxal and as a protein deglycase. Prior studies ascribed Hsp31 as a molecular chaperone that can inhibit α-Syn aggregation in vitro and alleviate its toxicity in vivo. It was also shown that Hsp31 inhibits Sup35 aggregate formation in yeast, however, it is unknown if Hsp31 can modulate [PSI+] phenotype and Sup35 prionogenesis. Other small heat shock proteins, Hsp26 and Hsp42 are known to be a part of a synergistic proteostasis network that inhibits Sup35 prion formation and promotes its disaggregation. Here, we establish that Hsp31 inhibits Sup35 [PSI+] prion formation in collaboration with a well-known disaggregase, Hsp104. Hsp31 transiently prevents prion induction but does not suppress induction upon prolonged expression of Sup35 indicating that Hsp31 can be overcome by larger aggregates. In addition, elevated levels of Hsp31 do not cure [PSI+] strains indicating that Hsp31 cannot intervene in a pre-existing prion oligomerization cycle. However, Hsp31 can modulate prion status in cooperation with Hsp104 because it inhibits Sup35 aggregate formation and potentiates [PSI+] prion curing upon overexpression of Hsp104. The absence of Hsp31 reduces [PSI+] prion curing by Hsp104 without influencing its ability to rescue cellular thermotolerance. Hsp31 did not synergize with Hsp42 to modulate the [PSI+] phenotype suggesting that both proteins act on similar stages of the prion cycle. We also showed that Hsp31 physically interacts with Hsp104 and together they prevent Sup35 prion toxicity to greater extent than if they were expressed individually. These results elucidate a mechanism for Hsp31 on prion modulation that suggest it acts at a distinct step early in the Sup35 aggregation process that is different from Hsp104. This is the first demonstration of the modulation of [PSI+] status by the chaperone action of Hsp31. The delineation of Hsp31's role in the chaperone cycle has implications for understanding the role of the DJ-1 superfamily in controlling misfolded proteins in neurodegenerative disease and cancer.
a Department of Medicinal Chemistry and Molecular Pharmacology and the Purdue University Center for Cancer Research , Purdue University , West Lafayette , IN , USA.
Kiran
K
Aslam
a Department of Medicinal Chemistry and Molecular Pharmacology and the Purdue University Center for Cancer Research , Purdue University , West Lafayette , IN , USA.
Chai-Jui
CJ
Tsai
a Department of Medicinal Chemistry and Molecular Pharmacology and the Purdue University Center for Cancer Research , Purdue University , West Lafayette , IN , USA.
Tony R
TR
Hazbun
D000222:Adaptation, Physiological; D004587:Electrophoresis, Agar Gel; D004591:Electrophoresis, Polyacrylamide Gel; D017353:Gene Deletion; D006360:Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D006358:Hot Temperature; D010454:Peptide Termination Factors / Q000378:metabolism*; D011328:Prions / Q000378:metabolism*; D011485:Protein Binding; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000378:metabolism; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism*
D006360:Heat-Shock Proteins; D010454:Peptide Termination Factors; D011328:Prions; C068068:SUP35 protein, S cerevisiae; D029701:Saccharomyces cerevisiae Proteins; C070972:HsP104 protein, S cerevisiae; C496117:HSP31 protein, S cerevisiae
Amyloids; Chaperone; DJ-1; Hsp104; Hsp31; Neurodegenerative diseases; Small Heat Shock Protein; Sup35; Yeast prion; [PSI+]
PLoS One. 2009;4(3):e4670
19262693
Mol Microbiol. 2000 Feb;35(4):865-76
10692163
Cell Death Dis. 2014 Jul 24;5:e1350
25058424
Genetics. 2011 Jul;188(3):565-77
21555396
EMBO J. 2008 Oct 22;27(20):2712-24
18833196
Nat Rev Mol Cell Biol. 2013 Oct;14(10):617-29
24061228
Biochim Biophys Acta. 2015 Mar;1854(3):218-28
25542374
EMBO J. 1999 Dec 1;18(23):6744-51
10581247
Science. 1995 May 12;268(5212):880-4
7754373
Hum Mol Genet. 2014 Feb 1;23 (3):755-66
24070869
Cell. 2009 Apr 3;137(1):146-58
19345193
PLoS Genet. 2015 Jan 08;11(1):e1004814
25568955
J Pathol. 2010 May;221(1):13-25
20186922
Yeast. 2007 Oct;24(10):913-9
17583893
Mol Cell Biol. 2001 Jul;21(14):4656-69
11416143
Essays Biochem. 2014;56:193-205
25131596
Prion. 2009 Apr-Jun;3(2):65-73
19556854
J Struct Biol. 2006 Oct;156(1):139-48
16563798
Eukaryot Cell. 2014 May;13(5):635-47
24632242
Nano Rev. 2011;2:null
22110868
Cell. 2005 Mar 11;120(5):715-27
15766533
Rev Physiol Biochem Pharmacol. 2007;159:1-77
17846922
Rejuvenation Res. 2010 Apr-Jun;13(2-3):220-3
20370497
PLoS One. 2015 Oct 14;10 (10 ):e0140363
26466368
Mol Cell Biol. 2010 Jul;30(14 ):3542-52
20479121
Nat Rev Cancer. 2011 Oct 24;11(11):812-23
22020207
PLoS One. 2009;4(3):e4539
19262694
PLoS One. 2012;7(6):e37692
22719845
Genetics. 2003 Sep;165(1):23-33
14504215
J Biol Chem. 2005 Jun 24;280(25):23861-8
15843375
J Biol Chem. 2004 Jul 16;279(29):30402-9
15084583
J Mol Biol. 2016 May 8;428(9 Pt B):1870-85
26608812
Prion. 2015;9(3):174-83
26110609
Mol Cell Biol. 2001 Nov;21(22):7569-75
11604493
Genetics. 2012 Aug;191(4):1041-72
22879407
Prion. 2016 Mar 3;10(2):103-11
27097320
Mol Microbiol. 2009 Sep;73(6):1101-14
19682262
PLoS Biol. 2012;10(6):e1001346
22723742
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):E2711-20
24938787
An Acad Bras Cienc. 2015 Aug;87(2 Suppl):1273-92
26312418
Yeast. 2010 Mar;27(3):159-66
20014044
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7012-7
24706893
J Biol Chem. 2015 Oct 9;290(41):24816-34
26306045
EMBO J. 2004 Feb 11;23(3):638-49
14749732
Prion. 2012 Jul 1;6(3):234-9
22561166
J Mol Biol. 2011 May 6;408(3):432-48
21392508
EMBO J. 1996 Jun 17;15(12):3127-34
8670813
J Biol Chem. 2011 Nov 25;286(47):40486-93
21969373
PLoS Genet. 2014 Oct 16;10(10):e1004720
25329162
J Biol Chem. 2005 Jun 24;280(25):23869-75
15845535
Biochem Biophys Res Commun. 2015 Aug 7;463(4):1305-10
26102038
Genetics. 2005 Mar;169(3):1227-42
15545639
Nat Commun. 2014 Jul 15;5:4384
25023996
Genetics. 1997 Oct;147(2):507-19
9335589
Prion. 2011 Oct-Dec;5(4):245-9
22052352
Prion. 2015;9(2):80-9
25738774
J Cell Biol. 2011 Nov 14;195(4):617-29
22065637
PLoS One. 2012;7(1):e29832
22253794
Front Mol Biosci. 2015 May 19;2:22
26042222
Protein Pept Lett. 2009;16(6):598-605
19519517
Biochem Pharmacol. 2015 Feb 1;93(3):241-50
25498803
Acta Crystallogr D Biol Crystallogr. 2015 Apr;71(Pt 4):882-95
25849399
J Biol Chem. 2015 Jan 16;290(3):1885-97
25416785